Prospective metastatic risk assignment in clinical stage I nonseminomatous germ cell testis cancer: A single institution pilot study

Urologic Oncology: Seminars and Original Investigations

Volumn 22, Issue 3, 2004, Pages 174-177

  Perrotti, Michael ^a   Ankem, Murali ^a   Bancilla, Anita ^a   DeCarvalho, Victor ^a   Amenta, Peter ^a   Weiss, Robert ^a  

^a ROBERT WOOD JOHNSON MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; CANCER INVASION; CANCER STAGING; CLINICAL ARTICLE; CONFERENCE PAPER; CONTROLLED STUDY; CORRELATION ANALYSIS; EMBRYONAL CARCINOMA; FISHER EXACT TEST; FOLLOW UP; HISTOPATHOLOGY; HUMAN; LEYDIG CELL TUMOR; MALE; METASTASIS; NON SEMINOMATOUS GERMINOMA; PILOT STUDY; PRIORITY JOURNAL; RISK ASSESSMENT; SEMINOMA; SERTOLI CELL TUMOR; STATISTICAL ANALYSIS; STATISTICAL SIGNIFICANCE; TESTIS CANCER;

ADULT; HUMANS; MALE; MIDDLE AGED; MODELS, THEORETICAL; NEOPLASM METASTASIS; NEOPLASMS, GERM CELL AND EMBRYONAL; PROGNOSIS; RISK ASSESSMENT; TESTICULAR NEOPLASMS;

EID: 3242659132     PISSN: 10781439     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.urolonc.2004.04.004     Document Type: Conference Paper

References (10)

1. Vergouwe Y., Steyerberg E.W., Eijkemans J.C., Albers P., Habbema J.D.F. Predictors of occult metastasis in clinical stage I nonseminoma a systematic review. J Clin Oncol. 21:2003;4092-4099
2. Feedman L.S., Jones W.G., Peckham M.J., et al. Histopathology in the prediction of relapse of patients with stage I testicular teratoma treated by orchidectomy alone. Lancet. 2:1987;294-298
3. Holtl W., Kosak D., Pont J., et al. Testicualr cancer prognostic implications of vascular invasion. J Urol. 137:1987;683-685
4. Klepp O., Olsson A.M., Henrikson H., et al. Prognostic factors in clinical stage I nonseminomatous germ cell tumours of the testis multivariate analysis of a prospective multicenter study. J Clin Oncol. 8:1990;509-518
5. Sogani P.C., Perrotti M., Herr H.W., et al. Clinical stage I testis cancer long term outcome of patients on surveillance. J Urol. 159:1998;855-858
6. Moul J.W., McCarthy W.F., Fernandez E.B., et al. Percentage of embryonal carcinoma and of vascular invasion predicts pathological stage in clinical stage I nonseminomatous testicular cancer. Can Res. 54:1994;362-364
7. Sweeney C.J., Hermans B.P., Heilman D.K., et al. Results and outcome of retroperitoneal lymph node dissection for clinical stage I embryonal carcinoma-predominant testis cancer. J Clin Oncol. 18:2000;358-362
8. Albers P., Siener R., Kliesch S., et al. Risk factors for relapse in clinical stage I nonseminomatous testicular germ cell tumors results of the German Testicular Cancer Study Group trial. J Clin Oncol. 21:2003;1505-1512
9. Klepp O., Dahl P., Flodgren P. Risk-adapted treatment of clinical stage I non-seminoma testis cancer. Eur J Cancer. 33:1997;1038-1044
10. Heidenreich A., Sesterhenn I.A., Mostofi F.K., et al. Prognostic risk factors that identify patients with clinical stage I nonseminomatous germ cell tumors at low risk and high risk for metastasis. Cancer. 83:1998;1002-1011